Ryerson Insider Claussen Files Form 4 on March 23, 2026

TL;DR

**Ryerson insider Claussen filed a Form 4, signaling a recent transaction; details pending.**

AI Summary

This Form 4 filing indicates that James J. Claussen, a reporting insider for Ryerson Holding Corp., filed a statement of changes in beneficial ownership of securities on March 23, 2026, for a transaction that occurred on March 19, 2026. While the filing confirms Claussen's status as an insider, it does not detail the specific transaction (buy, sell, or grant) or the number of shares involved. Investors should monitor subsequent filings or the full document to understand the nature and size of the transaction, as insider activity can signal management's confidence in the company's future.

Why It Matters

This filing confirms an insider transaction at Ryerson Holding Corp., which can provide clues about management's outlook on the company's stock performance. The specific details of the transaction, once available, will inform investors whether an insider is increasing or decreasing their stake.

Risk Assessment

Risk Level: low — This filing is merely a notification of an insider transaction, not an event that directly impacts the company's financials or operations.

Analyst Insight

A smart investor would mark this filing and await the full document or subsequent filings to determine the nature (buy/sell) and size of the transaction by James J. Claussen, as this information could influence their perception of Ryerson Holding Corp.'s future prospects.

Key Players & Entities

• Claussen James J (person) — Reporting insider for Ryerson Holding Corp.
• Ryerson Holding Corp (company) — The issuer of the securities
• March 23, 2026 (date) — Filing date of the Form 4
• March 19, 2026 (date) — Period of report for the transaction

FAQ

Filing Documents

• form4.html (4)
• form4.xml (4) — 9KB
• 0000899140-26-000340.txt ( ) — 11KB

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Claussen James J (Last) (First) (Middle) C/O RYERSON HOLDING CORPORATION 227 W. MONROE ST., 27TH FLOOR (Street) CHICAGO ILLINOIS 60606 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol Ryerson Holding Corp [ RYZ ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Executive Vice President & CFO 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/19/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Restricted Stock Units (1) 03/19/2026 A 38.913 (2) (3) (3) Common Stock 38.913 $ 0.00 4,218.615 D Restricted Stock Units (1) 03/19/2026 A 76.106 (2) (4) (4) Common Stock 76.106 $ 0 8,250.881 D Restricted Stock Units (1) 03/19/2026 A 125.918 (2) (5) (5) Common Stock 125.918 $ 0 13,651.098 D Explanation of Responses: 1. Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). 2. Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. 3. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of March 19, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026. 4. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of March 19, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026 and March 31, 2027. 5. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2025 and outstanding as of March 19, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026, March 31, 2027 and March 31, 2028. /s/ Camilla Rykke Merrick, attorney-in-fact 03/23/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form i

View Full Filing

View this 4 filing on SEC EDGAR